Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors - Differences in Excess Relative and Absolute Risk from Female Breast Cancer
- PMID: 27286002
- PMCID: PMC5289903
- DOI: 10.1289/EHP151
Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors - Differences in Excess Relative and Absolute Risk from Female Breast Cancer
Abstract
Background: There are well-known associations of ionizing radiation with female breast cancer, and emerging evidence also for male breast cancer. In the United Kingdom, female breast cancer following occupational radiation exposure is among that set of cancers eligible for state compensation and consideration is currently being given to an extension to include male breast cancer.
Objectives: We compare radiation-associated excess relative and absolute risks of male and female breast cancers.
Methods: Breast cancer incidence and mortality data in the Japanese atomic-bomb survivors were analyzed using relative and absolute risk models via Poisson regression.
Results: We observed significant (p ≤ 0.01) dose-related excess risk for male breast cancer incidence and mortality. For incidence and mortality data, there are elevations by factors of approximately 15 and 5, respectively, of relative risk for male compared with female breast cancer incidence, the former borderline significant (p = 0.050). In contrast, for incidence and mortality data, there are elevations by factors of approximately 20 and 10, respectively, of female absolute risk compared with male, both statistically significant (p < 0.001). There are no indications of differences between the sexes in age/time-since-exposure/age-at-exposure modifications to the relative or absolute excess risk. The probability of causation of male breast cancer following radiation exposure exceeds by at least a factor of 5 that of many other malignancies.
Conclusions: There is evidence of much higher radiation-associated relative risk for male than for female breast cancer, although absolute excess risks for males are much less than for females. However, the small number of male cases and deaths suggests a degree of caution in interpretation of this finding. Citation: Little MP, McElvenny DM. 2017. Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors - differences in excess relative and absolute risk from female breast cancer. Environ Health Perspect 125:223-229; http://dx.doi.org/10.1289/EHP151.
Conflict of interest statement
The conclusions in this report are those of the authors and do not necessarily reflect the scientific judgment of RERF or its funding agencies. D.M.M. is a director at Statistics Analysis and Health Limited, UK, a consultancy service to industry and to the legal profession. D.M.M. is also listed as a potential expert witness and consultant at the Institute of Occupational Medicine, where he works. As such, D.M.M. occasionally does medico-legal work but has never done any in relation to ionizing radiation exposure and any health outcome. Although there is a potential competing financial interest for D.M.M. in relation to the present analysis, in practice there is none. M.P.L. declares he has no actual or potential competing financial interests.
Similar articles
-
Male breast cancer incidence among atomic bomb survivors.J Natl Cancer Inst. 2005 Apr 20;97(8):603-5. doi: 10.1093/jnci/dji097. J Natl Cancer Inst. 2005. PMID: 15840883
-
Cancer and non-cancer effects in Japanese atomic bomb survivors.J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19. J Radiol Prot. 2009. PMID: 19454804 Review.
-
Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.Int J Radiat Biol. 2001 Apr;77(4):431-64. doi: 10.1080/09553000010022634. Int J Radiat Biol. 2001. PMID: 11304437
-
Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors.Radiat Res. 1999 Feb;151(2):218-24. Radiat Res. 1999. PMID: 9952307
-
Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.Radiat Res. 1994 Feb;137(2 Suppl):S17-67. Radiat Res. 1994. PMID: 8127952 Review.
Cited by
-
Image-based screening for men at high risk for breast cancer: Benefits and drawbacks.Clin Imaging. 2020 Mar;60(1):84-89. doi: 10.1016/j.clinimag.2019.11.005. Epub 2019 Nov 28. Clin Imaging. 2020. PMID: 31864206 Free PMC article. Review.
-
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship.Curr Oncol Rep. 2024 Jan;26(1):34-45. doi: 10.1007/s11912-023-01489-z. Epub 2024 Jan 2. Curr Oncol Rep. 2024. PMID: 38224426 Review.
-
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.Tumour Biol. 2016 Oct;37(10):12941-12957. doi: 10.1007/s13277-016-5168-x. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448308 Review.
-
Epidemiological, anatomopathological and immunohistochemical profiles of male breast cancer in Sidi Bel Abbes, Algeria (Profiles of male breast cancer).Malawi Med J. 2024 Jul 30;36(2):115-119. doi: 10.4314/mmj.v36i2.8. eCollection 2024 Jul. Malawi Med J. 2024. PMID: 40191556 Free PMC article.
-
Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.EPMA J. 2018 Feb 8;9(1):1-13. doi: 10.1007/s13167-018-0129-7. eCollection 2018 Mar. EPMA J. 2018. PMID: 29515683 Free PMC article. Review.
References
-
- Akaike H. Budapest, Hungary: Akadémiai Kiadó; 1973. Information theory and an extension of the maximum likelihood principle. In: 2nd International Symposium on Information Theory. Petrov BN, Czáki F, eds. pp. 267–281.
-
- Akaike H. Likelihood of a model and information criteria. J Econom. 1981;16:3–14.
-
- Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007;8:292–293. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases